El Salvador vs Western Pacific (WHO region): Hypertension effective treatment coverage (controlled hypertension)
El Salvador
39.4%
in 2019
Western Pacific (WHO region)
18.4%
in 2019
El Salvador rank
9th
Western Pacific (WHO region) rank
6th
Hypertension effective treatment coverage (controlled hypertension) over time
- El Salvador
- Western Pacific (WHO region)
How they compare
El Salvador currently reports 39.4% against 18.4% in Western Pacific (WHO region), a difference of 21.0%.
That makes El Salvador's figure about 2.1 times Western Pacific (WHO region)'s.
Across all 30 years both countries report, El Salvador has been ahead every year.
El Salvador ranks 9th and Western Pacific (WHO region) ranks 6th of 193 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14.0% | 4.7% | 9.4% | El Salvador |
| 2000s | 23.3% | 9.9% | 13.4% | El Salvador |
| 2010s | 35.5% | 16.5% | 19.0% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), El Salvador or Western Pacific (WHO region)?
- El Salvador, at 39.4% against 18.4% in Western Pacific (WHO region) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between El Salvador and Western Pacific (WHO region)?
- 21.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Western Pacific (WHO region)?
- 30 years are reported by both, from 1990 to 2019.
- How do El Salvador and Western Pacific (WHO region) rank globally for hypertension effective treatment coverage (controlled hypertension)?
- El Salvador ranks 9th and Western Pacific (WHO region) ranks 6th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.